CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENTConvertible Promissory Note Conversion Agreement • October 11th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Convertible Promissory Note Conversion Agreement (this “Agreement”) is made and entered into as of , 2019 by and between NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and , a corporation (the “Noteholder”), with reference to the following:
EVOLUS, INC. CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENTConvertible Promissory Note Conversion Agreement • May 12th, 2021 • Evolus, Inc. • Pharmaceutical preparations • Delaware
This Convertible Promissory Note Conversion Agreement (this “Agreement”) is made as of March 23, 2021, by and among Evolus, Inc., a Delaware corporation (the “Company”), and Daewoong Pharmaceutical Co., Ltd. (the “Holder”).
CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENTConvertible Promissory Note Conversion Agreement • January 18th, 2008 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENT (this “Agreement”) is made and entered into this 19th day of December 2007 by and among OSIRIS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the person(s) listed on and executing the signature page hereto or a counterpart thereof (each, a “Noteholder” and collectively, the “Noteholders”).
CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENTConvertible Promissory Note Conversion Agreement • October 3rd, 2013 • Reven Housing REIT, Inc. • Real estate investment trusts • California
This CONVERTIBLE PROMISSORY NOTE CONVERSION AGREEMENT (this “Agreement”) is entered into and effective as of September 27, 2013 (the “Effective Date”) by and among the undersigned, each of whom have executed the Note Holder signature pages attached hereto as Annex A (each, a “Note Holder” and collectively, the “Note Holders”), and REVEN HOUSING REIT, INC., a Colorado corporation (the “Company”), with reference to the following facts:
Monaker Group, Inc. 10-QConvertible Promissory Note Conversion Agreement • July 20th, 2016 • Monaker Group, Inc. • Services-advertising
As per the Second Note Amendment dated May 15, 2015, between Monaker Group, Inc. (formerly known as Next 1 Interactive, Inc.) and Mark Wilton, Monaker Group, Inc., Monaker Group hereby exercises its right under section 4 of the Second Note Amendment and is converting $1,500,000 of your outstanding Convertible Promissory Note into 750,000 Monaker common stock based upon a price of $2.00, which represents 80% of the five day trailing average closing price of Monaker Common Stock as of February 26, 2015. This $1,500,000 conversion will reduce the current balance of Note A of $1,409,326.
